Marylou Behnke, M.D.

Marylou BehnkeDivision


Academic Title


Contact Information

352-273-8985 (phone)
352-273-9054 (fax)

Research Overview

Effects of perinatal risk factors on long-term outcome.

Active Research Projects/Grants

  • 3RO1DA05854-16S1 NIH/NIDA (PI: Eyler)
    Project CARE Administrative Supplement
    Role: Co-PI of this supplemental funding for cohort maintenance
  • University of Florida, Opportunity Incentive Seed Fund (PI: Warner)
    Project CARE: Brain Development and Behavior in Adolescents
    Role: Co-PI of this grant to examine the effects of adolescent cocaine use and prenatal cocaine exposure on brain development using neuroimaging studies

Key Publications

  1. Behnke M, Eyler FD, Garvan CW, Wobie K, Hou W: Cocaine exposure and developmental outcome from birth to six months. Neurotoxicol Teratol 24:283-295, 2002.
  2. Saxonhouse MA, Behnke M, Williams JL, Richards D, Weiss MD: Mucopolysaccharidosis type VII presenting with isolated neonatal ascites. J Perinatol 23:73-75, 2003.
  3. Wobie K, Eyler FD, Garvan CG, Hou W, Behnke M: Prenatal cocaine exposure: An examination of mother/infant separation during the first year of life. J Drug Issues 34:77-94, 2004.
  4. Hou W, Wang Z, Garvan CW, Behnke M, Eyler FD, Wu R: A generalized model for detecting genetic determinants underlying longitudinal traits with unequally spaced measurements and time-dependent correlated errors. Biostatistics 6:420-433, 2005.
  5. Eyler FD, Behnke M, Wobie K, Garvan CW, Tebbett I: Relative ability of biologic specimens and interviews to detect prenatal cocaine use. Neurotoxicol Teratol 27:677-687, 2005.
  6. Behnke M, Eyler FD, Warner TD, Garvan CW, Hou W, Wobie K: Outcome from a prospective, longitudinal study of prenatal cocaine use: Preschool development at 3 years of age. J Pediatr Psychol 31:41-49, 2006.
  7. Dow-Edwards DL, Benveniste H, Behnke M, Bandstra ES, Singer LT, Hurd YL, Stanford LR: Neuroimaging of prenatal drug exposure. Neurotoxicol Teratol 28:386-402, 2006.
  8. Warner TD, Behnke M, Hou W, Garvan CW, Wobie K, Eyler FD: Predicting caregiver reported behavior problems in cocaine-exposed children at 3 years. J Behav Dev Pediatr 27:83-92, 2006.
  9. Warner TD, Behnke M, Eyler FD, Padgett K, Leonard CM, Hou W, Garvan CW, Schmalfuss IM, Blackband SJ: Diffusion Tensor Imaging of Frontal White Matter and Executive Functioning in Cocaine-Exposed Children Pediatrics 118:2014-2024, 2006.
  10. Hou W, Garvan CW, Littell RC, Behnke M, Eyler FD, Wu R: A framework to monitor environment-induced major genes for developmental trajectories: Implication for a prenatal cocaine exposure study. Statistics in Medicine 25:4020-4035, 2006.